Cancer immunotherapy has proven efficacy in some cancer subtypes but it often fails to deliver clinically meaningful benefits to patients because their tumors are poorly immunogenic. A major goal of ...

For the most part, we’re fans of Roku’s friendly, intuitive remotes, and particularly the ones that have voice capabilities. But there’s a sticking point—four of them, actually—when it comes to the ...

The biotech firm’s polyclonal anti-cancer therapy is based on an ex vivo approach and avoids the use of toxic immune-depleting chemotherapy. Rapa Therapeutics (Rapa) is bringing the power of ...